Platinum analogs as potential new drugs for bladder cancer

Expression of genes related to activity of oxaliplatin and 5-fluorouracil in endoscopic biopsies of primary esophageal cancer in patients receiving oxaliplatin, 5-flourouracil and radiation: characterization and exploratory analysis with survival.

Journal of chemotherapy (Florence, Italy)·2006

S-phase modulation by irinotecan: pilot studies in advanced solid tumors.

Cancer chemotherapy and pharmacology·2005

A phase I and pharmacokinetic study of BAY59: a novel taxane.

Oncology·2004

Phase I/pharmacodynamic study of N-acetylcysteine/oltipraz in smokers: early termination due to excessive toxicity.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2001

Oral uracil and Ftorafur plus leucovorin: pharmacokinetics and toxicity in patients with metastatic cancer.

Cancer chemotherapy and pharmacology·2000

Phase I and pharmacokinetic study of weekly 5-fluorouracil administered with granulocyte-macrophage colony-stimulating factor and high-dose leucovorin: a potential role for growth factor as mucosal protectant.

Cancer investigation·2000

The Effect Of Metronome Rhythm On Pain, Anxiety, And Patient Experience During Cystoscopy: A Prospective Clinical Study.

Urology·2026

Safety of Right-Sided Minimally Invasive Living Donor Nephrectomy: A Contemporary National Registry Analysis of 29,874 Transplants.

Urology·2026

Telehealth in Urologic Oncology: Temporal Trends and Patient Characteristics in the United States.

Urology·2026

Benign Prostatic Hyperplasia Pharmacotherapy and Incident Ocular Surface Disease: Comparative Risk of Alpha-Blockers Versus 5-Alpha Reductase Inhibitors.

Urology·2026

Firearm-Related External Genital Trauma: Contemporary Management Strategies and Outcomes to Inform Urologic Trauma Guidelines.

Urology·2026

Cost-Effectiveness of Contemporary Surgical Treatment Options for Benign Prostatic Hyperplasia.

Urology·2026

EGFR kinase inhibitors from novel thiazole derivatives: synthesis, anticolon cancer, docking, and ADME studies.

Future medicinal chemistry·2026

Beyond the ceiling: A critical analysis of microRNA research in cutaneous T-cell lymphoma and a roadmap forward.

The Journal of investigative dermatology·2026

Tumor-Secreted ADAMTSL4 Activates Latent TGFβ1 to Drive Cancer Cachexia.

Cancer discovery·2026

Epigenetic Repression of Type I Interferon Signaling by RUNX2 Drives Immune Checkpoint Blockade Resistance in Osteosarcoma.

Cancer research·2026

The Trispecific Antibody IBI3019 Integrates CDH17-Enhanced EGFR Antagonism with Optimized CD16A Engagement to Elicit Potent Antitumor Activity with Minimal Toxicity.

Cancer research·2026

Targeting glutaminase (GLS) to suppress CXCL8 secretion and sensitize esophageal squamous cell carcinoma to immunotherapy.

Journal of chemotherapy (Florence, Italy)·2026

Related Experiment Videos

Platinum analogs as potential new drugs for bladder cancer

Related Concept Videos

Expression of genes related to activity of oxaliplatin and 5-fluorouracil in endoscopic biopsies of primary esophageal cancer in patients receiving oxaliplatin, 5-flourouracil and radiation: characterization and exploratory analysis with survival.

S-phase modulation by irinotecan: pilot studies in advanced solid tumors.

A phase I and pharmacokinetic study of BAY59: a novel taxane.

Phase I/pharmacodynamic study of N-acetylcysteine/oltipraz in smokers: early termination due to excessive toxicity.

Oral uracil and Ftorafur plus leucovorin: pharmacokinetics and toxicity in patients with metastatic cancer.

Phase I and pharmacokinetic study of weekly 5-fluorouracil administered with granulocyte-macrophage colony-stimulating factor and high-dose leucovorin: a potential role for growth factor as mucosal protectant.

The Effect Of Metronome Rhythm On Pain, Anxiety, And Patient Experience During Cystoscopy: A Prospective Clinical Study.

Safety of Right-Sided Minimally Invasive Living Donor Nephrectomy: A Contemporary National Registry Analysis of 29,874 Transplants.

Telehealth in Urologic Oncology: Temporal Trends and Patient Characteristics in the United States.

Benign Prostatic Hyperplasia Pharmacotherapy and Incident Ocular Surface Disease: Comparative Risk of Alpha-Blockers Versus 5-Alpha Reductase Inhibitors.

Firearm-Related External Genital Trauma: Contemporary Management Strategies and Outcomes to Inform Urologic Trauma Guidelines.

Cost-Effectiveness of Contemporary Surgical Treatment Options for Benign Prostatic Hyperplasia.

EGFR kinase inhibitors from novel thiazole derivatives: synthesis, anticolon cancer, docking, and ADME studies.

Beyond the ceiling: A critical analysis of microRNA research in cutaneous T-cell lymphoma and a roadmap forward.

Tumor-Secreted ADAMTSL4 Activates Latent TGFβ1 to Drive Cancer Cachexia.

Epigenetic Repression of Type I Interferon Signaling by RUNX2 Drives Immune Checkpoint Blockade Resistance in Osteosarcoma.

The Trispecific Antibody IBI3019 Integrates CDH17-Enhanced EGFR Antagonism with Optimized CD16A Engagement to Elicit Potent Antitumor Activity with Minimal Toxicity.

Targeting glutaminase (GLS) to suppress CXCL8 secretion and sensitize esophageal squamous cell carcinoma to immunotherapy.

Related Experiment Videos

Platinum analogs as potential new drugs for bladder cancer

Related Concept Videos

Related Articles